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Abstract
siRNA (small interfering RNA) and shRNA (small hairpin RNA) are powerful and commonly used tools in biomedical research.
Currently, siRNAs are generally designed as two 21 nt strands of RNA that include a 19 nt completely complementary part
and a 2 nt overhang. However, since the si/shRNAs use the endogenous miRNA machinery for gene silencing and the
miRNAs are generally 22 nt in length and contain multiple internal mismatches, we tested if the functionality can be
increased by designing the si/shRNAs to mimic a miRNA structure. We systematically investigated the effect of single or
multiple mismatches introduced in the passenger strand at different positions on siRNA functionality. Mismatches at certain
positions could significantly increase the functionality of siRNAs and also, in some cases decreased the unwanted passenger
strand functionality. The same strategy could also be used to design shRNAs. Finally, we showed that both si and miRNA
structured oligos (siRNA with or without mismatches in the passenger strand) can repress targets in all individual Ago
containing cells, suggesting that the Ago proteins do not differentiate between si/miRNA-based structure for silencing
activity.
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Introduction
siRNA/shRNA is one of the most powerful and commonly used
tool for biomedical research and is also being explored as
therapeutic candidates for a number of diseases. The design of
siRNAs has undergone tremendous improvements over the years
and several algorithms have been developed to roughly predict
functionality by studying large sets of siRNAs [1,2,3,4,5,6,
7,8,9,10,11]. These algorithms commonly choose defined regions
in the target to design siRNAs. Usually more than enough regions
are available to design good siRNA candidates. However, in some
cases, only limited target sequences are available. For example,
highly conserved target regions must be used to design siRNAs for
suppression of viral infections to avoid rapid emergence of escape
mutants and such conserved regions are few and are often not the
ideal sequences predicted by currently available algorithms for
siRNA design. Thus, there is still a need to improve siRNA design.
In mammals, exogenously introduced siRNA and shRNA have
to be processed by endogenous microRNA (miRNA) machinery in
order to be functional. Thus, understanding miRNA biogenesis
can provide insights into designing better RNAi strategies for
application. miRNAs are genomically encoded and are transcribed
as long primary transcripts (pri-miRNAs) that are processed by
Drosha and Dicer into ,65 nucleotides (nt) pre-miRNA and
,22 nt mature miRNA duplex respectively [12,13,14,15,16,
17,18,19,20,21]. Generally one (guide) strand of duplex is loaded
into RISC to repress target gene expression while the other
(passenger) strand is discarded [22,23,24,25]. siRNAs or shRNAs
can be considered as analogs of intermediate products at different
stages of miRNA biogenesis—siRNA representing mature miRNA
duplex and shRNA representing pre or pri-miRNA. Currently,
siRNAs are generally designed as two 21 nt strands of RNA that
include 19 nt completely complementary sequences and 2 nt 39
overhangs [7,26,27,28]. However, the natural substrates of the
miRNA loading system—the endogenously generated miRNA
duplexes are typically 22 nt in length [29,30] and have multiple
internal mismatches. In this study, we find that siRNA
functionality can be improved if conventional siRNA is changed
to have a miRNA duplex-like structure by increasing the length to
22 nt and introducing mismatches into the duplex.
Results
Many conventional siRNAs was nonfunctional
In an earlier study, we have shown that a single siRNA targeting
a highly conserved region in the flaviviral genome can suppress
fatal encephalitis induced by two neurotropic flaviviruses, Japanese
encephalitis virus (JEV) and West Nile virus (WNV) [31]. To
increase the repertoire of such siRNAs, we tested an additional 25
siRNAs targeting highly conserved regions in the viral genome
[32]. Out of these 25 siRNAs, only 7 could inhibit virus infection
by more than 60% (Figure 1a of reference [32]). To understand
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28580why most siRNAs did not work, we selected 13 siRNAs including
some that worked and many that did not. We performed dual
luciferase assays using target sequences in the Renilla luciferase 39
UTR. Both strands of siRNAs were tested for functionality using
luciferase reporters containing the guide or the passenger strand
target sequences in the 39 UTR. Overall, the siRNA functionality
tested with luciferase assay correlated well with virus inhibition
results. Although neither strand was functional in many cases
where the siRNA was ineffective, in some cases such as siR-13 and
siR-03, the passenger strand was more efficient than the intended
guide strand in target repression (Fig. 1).
The effect of mismatches on the functionality of siRNA
For broad-spectrum antiviral activity, siRNAs targeting highly
conserved target regions that are shared between viruses need to
be used. However, such shared sequences are relatively rare and
this imposes restriction on target regions and sequences to be used
for siRNA design. We hypothesized that designing siRNAs to
mimic the miRNA structure might convert the low or nonfunc-
tional siRNAs to potent siRNAs. In fact, most natural miRNA
duplexes are 22 nt in length [29,30] and have internal mismatches
that are highly conserved across species, suggesting that these are
important structural features of miRNA duplexes. Thus, we tested
if increasing the length to 22 nt and introducing mismatches in the
passenger strand (without changing the guide strand sequence) of
siRNAs to mimic miRNA duplexes might improve the siRNA
functionality. Initially, we redesigned 3 non-working siRNAs by
increasing the length to 22 nt and introducing mismatches at
position 1 and 12, which are generally the most unstable sites in
miRNAs according to Han et al [17]. This was enough to increase
the siRNA functionality in all 3 cases in luciferase assays (Fig. S1).
Encouraged by these results, we attempted to systematically
determine the optimal mismatch structure of siRNA for efficient
gene silencing. We introduced single or multiple mismatches at
various positions shown in Fig. 2a to siR-21, which showed no
functionality with conventional siRNA structure shown in Fig. 1.
Just changing the length of siR-21 to 22 nt by replacing the 39
dTdT with 3 nt that is perfectly complementary to the target sites
without any mismatches (m0) increased the functionality of siR-21.
A single mismatch in the passenger strand corresponding to guide
strand position 1 (m1) or central positions, such as 10, 11, 12
increased the siRNA functionality (Fig. 2a, left). We next tested
combinations of mismatches that results in the highest function-
ality. Introducing 2 or 3 mismatches increased the functionality
further (Fig. 2a, right). To verify the results in another siRNA
context, we introduced mismatches to a siRNA targeting the CS2
region of flavivirus. The CS2 region is the most conserved regions
in all mosquito-borne flaviviruses and is repeated twice in the
genome and thus, it is an ideal target to repress mosquito-borne
flaviviruses across species. In this siRNA, a single mismatch at
position 1, 4 or 10 increased the siRNA functionality, and the
mismatch combinations m1+3+10 and m1+4+10 show the highest
functionality (Fig. 2b).
To confirm the improved functionality of mismatched siRNAs,
we determined the IC50 for different mismatch structures for 2
siRNAs, siR-21 and siCS2 by testing at different concentrations.
As shown in Fig. 2c, the IC50 of mismatched siRNAs was much
smaller than completely complementary siRNA for both the
siRNAs tested, suggesting that mismatches improved efficacy
dramatically. Examination of the siRNA titration curve shown in
Fig. 2d suggests that although an improvement in functionality of
mismatched siRNA was evident at each concentration tested, the
improvement was much more pronounced at limiting siRNA
concentrations (Fig. 2d).
It is generally believed that GC rich sequences (.50%) are not
suitable for siRNA design because of high thermodynamic stability
[7,27,33]. Because mismatches would significantly decrease the
thermodynamic stability, we suspected that adding mismatches
might even be able to convert GC rich sequences into efficient
siRNAs. To test the hypothesis, we designed siRNAs to target an
artificial sequence that consists of 100% GC. Surprisingly,
m1+4+10 structure showed a small, but statistically significant
repression effect while more mismatches did not increase the
functionality (Fig. 2e).
The results presented above are consistent with two recent
studies that showed that central mismatches facilitate RISC
loading, and additional mismatches within the seed were needed
to facilitate RISC maturation in Drosophila as well as mammalian
cells [34,35]. Although the above studies found that mid region
mismatches promote RISC loading, we found that introducing
one more mismatch in position 15 did not increase the
functionality. In summary, it appears that introducing mismatches
Figure 1. The functionality of conventional siRNAs targeting conserved regions in the flaviviral genome. Dual luciferase assay
performed 24 hours after co-transfection of indicated siRNAs with the reporter vector psiCHECK2 harboring the siRNA target sequences. Target
sequences of guide strand (white bars) or passenger strand (black bars) were inserted into the 39 UTR of Renilla luciferase gene to test the intended or
passenger strand functionality. The ratio of Renilla luciferase (Rluc, reporter) to firefly luciferase (Fluc, internal control), normalized to the negative
control siRNA (siGFP) is shown. The experiments were performed in triplicate. Error bar=1 S.D.
doi:10.1371/journal.pone.0028580.g001
MicroRNA Mimicking siRNA
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(position 4–7), and central region (position 9–12), can increase
siRNA functionality.
Optimized structure could increase the functionality of
siRNA in general
Next, we tested if the optimal structure could be generalized to
other siRNAs. Based on Fig. 2 results, we choose m1+4+10 as the
relatively optimal siRNA structure to test the hypothesis. Seven
WNV siRNAs that did not work in Fig. 1 were redesigned to have
the optimal structure—22 nt in length and mismatch in the
passenger strand corresponding to guide strand positions 1, 4 and
10 (m1+4+10). siRNAs without mismatches, but with the length
increased to 22 nt (m0) were also included to test the effects of
mismatches. In almost all cases, the redesigned siRNAs with
mismatches at position 1, 4 and 10 (m1+4+10) had significantly
higher functionality in the reporter luciferase assays compared to
the conventional siRNAs (Fig. 3a). Consistent with previous
observation with siR-21, just changing the length of siRNAs to
22 nt by replacing the 39 dTdT with 3 nt that is perfectly
complementary to the target sites without any mismatches (m0)
generally increased the functionality siRNAs but introducing
m1+4+10 mismatches further improved the functionality com-
pared to m0 in 5 out of 7 siRNAs tested (Fig. 3a). The 8 redesigned
siRNAs were also tested for their ability to inhibit West Nile Virus
infection. Consistent with the results obtained with the luciferase
assay, the redesigned siRNAs inhibited viral replication more
efficiently compared to the conventional siRNAs in most cases (see
Figure 1a of reference [32] and Fig. 3b). In 6 out of 8 cases,
m1+4+10 showed significantly higher inhibition efficacy compared
with the no mismatch 22 nt siRNAs (Fig. 3b).
Next, we randomly selected 27 targets from c-myb 39 UTR with
GC content ranging from 40 to 75% and designed siRNAs with no
mismatch passenger strand or mismatched passenger strand at
position 1, 4 and 10 (m1+4+10). The target sequences with GC
contentlowerthan40%werepurposelynotselectedbecausesiRNAs
with low GC content tend to disassociate when multiple mismatches
are introduced. As shown in Fig. 3c, siRNAs with m1+4+10
structure showed significantly higher functionality compared to the
no mismatch structure (m0) in 56% siRNAs (15 out of 27). Of note,
none of the siRNAs with m1+4+10 structure showed significantly
lower functionality compared with m0 structure.
In summary, introducing mismatches at position 1, 4 and 10
could increase siRNA functionality in a majority of siRNAs tested.
However, it did not improve siRNA functionality in some siRNAs.
Figure 2. The effect of mismatches on siRNA functionality. (a) Keeping the guide strand sequence intact, single (left) or multiple (right)
mismatches were introduced to the siR-21 passenger strand at the indicated positions corresponding to the guide strand 59 end and functionality
was assessed as in Fig. 1. C indicates 21 nt completely complementary siRNA, m0 represents 22 nt siRNA with no mismatch, m1 represents a single
mismatch at position 1, m1+9 represent 2 mismatches at position 1 and 9 and so on. The bar graphs represent mean of triplicate. Error bar=1 S.D. (b)
Single or multiple mismatches were introduced to siCS2, a siRNA targeting highly conserved CS2 region of all mosquito-borne flaviviruses, at the
indicated positions and the functionality was assessed as in Fig. 1. (c) IC50 was calculated for siR-21 and siCS2 with different mismatch structures
based on the graph generated by testing different mismatched structures at indicated concentrations in (d). (e) Single or multiple mismatches were
introduced to a siRNA targeting an artificial 100% GC sequence at the indicated positions and the functionality was assessed as in Fig. 1.
doi:10.1371/journal.pone.0028580.g002
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RISC loading
One of the concerns with siRNA application is the off-target
effect caused by the passenger strand loading into RISC. Often,
passenger strand is also loaded [33,36,37,38,39,40]. In this study,
the passenger strand was even more efficient than the intended
strand in target repression in the case of siR-03 and siR-13 (Fig. 1).
It has been reported that the end thermodynamic stability
dominates strand selection. Because introducing mismatches at
position 1, 4, and 10 changes the thermodynamic stability of the
siRNA, the loading of the passenger strand might be decreased
resulting in reduced off-target effects. To test this hypothesis, we
determined the passenger strand functionality in 4 siRNAs in
which the functionality of the intended strand had been tested. In
2 of 4 siRNAs, the functionality of passenger strand was
significantly decreased (Fig. 4). Thus, introducing mismatches to
the passenger strand might reduce the off-target effect caused by
passenger strand loading, at least in some cases.
Introducing mismatches could also increase the
functionality of shRNA
We hypothesized that the optimal mismatch structures might
also be applied to shRNA design to enhance functionality since the
shRNAs would be processed into duplexes and finally subjected to
RISC loading. Currently shRNAs are commonly designed to
generate perfectly complementary strands [41,42,43,44,45]. Thus,
we tested if introducing m1+4+10 mismatches can enhance
functionality compared to perfectly complementary shRNAs. For
this purpose, we converted two siRNAs, siR-21 and a siRNA
targeting the most conserved regions in HIV 59 UTR [46], into
Figure 3. Introducing mismatches at position 1, 4 and 10 could generally increase siRNA functionality. (a) siRNAs that were not highly
functional in Fig. 1 were redesigned to have 22 nt length and mismatches at position 1, 4 and 10 (m1+4+10) and tested for efficacy as in Fig. 1. (b)
The redesigned siRNAs in Fig. 3a were tested for inhibition of West Nile virus replication. BHK21 cells were transfected with the indicated siRNAs and
8 h later, infected with WNV (moi=1). Three days after infection, cells were stained with anti-West Nile Virus/Kunjin Envelope antibody and analyzed
by flow cytometry to determine inhibition of virus replication. FVE
jw siRNA [31] was used as positive control and the data were normalized using a
negative control siLuc siRNA. The bar graphs represent mean +/2 SD of triplicates. (c) siRNAs targeting c-myb 39 UTR were designed to have either no
mismatches (m0, white) or mismatches at position 1, 4 and 10 (m1+4+10, black). The siRNA numbers represent the starting position of target
sequence in c-myb 39 UTR. The functionality was assessed as in Fig. 1. P values between m0 and m1+4+10 were shown below the figure.
doi:10.1371/journal.pone.0028580.g003
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mismatch structure (m0), the efficacy significantly improved with
m1+4+10 mismatches introduced in the passenger strand (Fig. 5).
Of note, the results with shRNA were consistent with synthetic
siRNAs (Fig. 2a and Fig. S2).
All 4 Argonaute proteins can load both si and miRNA
structured oligos to generate active RISC
The four Argonaute proteins Ago1–4 constitute key compo-
nents of RISC in mammalian cells [47]. In Drosophila, it has been
reported that siRNAs are sorted into Ago2 while miRNAs with
mismatches are sorted into Ago1 [48,49,50]. In mammals, such
sorting does not occur and both mi and siRNAs can associate with
all Ago proteins. However, a recent report suggests that while
miRNA duplexes could be bound as well as unwound by all Ago
proteins, siRNA duplexes could only be efficiently unwound by
Ago2, although Ago1, 3 and 4 could also bind the siRNA in vitro
[34,35]. If this is the case, conventional siRNA should only be
selected into Ago2, while miRNA-mimicking siRNAs should be
able to be selected into all 4 Ago proteins, which might explain
why designing siRNA to have a miRNA structure could increase
the functionality. We therefore tested the repression efficacy of
complementary and mismatched siRNA duplexes in mouse ES
cells knocked out for all Agos followed by reconstitution with
individual Agos [51] as well as in the parental NM5 ES cells
expressing all 4 Ago proteins. We chose a siRNA, FVE
jw that did
not show any functional difference when mismatches are
introduced into the passenger strand. For this experiment,
luciferase reporter containing completely complementary target
sequences in the 39UTR were cotransfected with FVE
jw siRNAs
with or without mismatches in the passenger strand (thus the guide
strand of both siRNAs had completely complementary target
sequences in the reporter) into ES cells containing Ago1, Ago2,
Ago3, Ago4 or the parental ES cells containing all Ago proteins
(NM5). As expected, the Ago2 cells showed the greatest repression
corresponding to its cleavage activity, whereas in Ago1, 3 and 4
cell lines, miRNA like repression accounted for the (not so
profound as Ago2) reduction in target activity (with both siRNAs
with or without mismatches in the passenger strand). Although the
degree of repression varied between Ago2 and Ago 1, 3 and 4 cells,
it is important to note that the functionality between m0 and
m1+4+10 structure displayed no significant differences in Ago 1, 2,
3, or 4 cells, suggesting that all individual Ago proteins could load
complementary as well as mismatched siRNA to generate active
RISC similarly (Fig. 6a).
The results in another two siRNAs were consistent with FVE
jw
results (Fig. 6b and 6c). In these two siRNAs, although
mismatched siRNAs showed higher functionality in all cells, no
mismatch siRNAs was clearly also functional in Ago 1, 3 and 4
cells just like in Ago2 and parental cells. Taken together, our
results suggest that irrespective of the extent or mechanism of
target knockdown (cleavage or miRNA like repression), both si and
miRNA structured oligos (siRNA with or without mismatches in
the passenger strand) are loaded into all Ago proteins and thus, the
Ago proteins do not differentiate between si/miRNA-based
structure for loading or maturation.
It is not surprising that the repression was more marked in Ago2
ES cells because Ago2 could cleave the target while Ago1, 3 and 4
could only repress the target by translational repression. However,
it is interesting that the repression efficacy was significantly higher
in Ago2 ES cells than in parental ES cells with all the Ago proteins.
A recent paper reported that Ago2 was the primary rate-limiting
determinant of siRNA efficacy and Ago 1, 3 and 4 could compete
with Ago2 for siRNA loading [52]. This might explain the higher
repression efficacy seen in Ago2 only expressing ES cells compared
to the parental cell expressing all Ago proteins.
The effect of mismatch might depend on the siRNA
sequence context
To further dissect the contribution of mismatches at different
positions in different siRNA context, we picked 5 siRNAs from the
siRNAs targeting c-myb 39 UTR that showed significant
improvement when mismatches are introduced and compared
the functionality with different mismatch structures. As shown in
Fig. 7, introducing mismatch at the end (m1) or m1+4 increased
the functionality to similar extent. However, introducing mis-
matches at more internal positions in m1+10 or m1+4+10 led to a
significantly enhanced functionality for almost all the siRNAs
Figure 4. Mismatched structure could decrease the loading of
passenger strand. The passenger strand functionality was compared
between no mismatch (m0, white bars) and mismatched (m1+4+10,
black bars) structure by co-transfecting the indicated siRNAs with
psiCHECK2 vector harboring the corresponding perfectly complemen-
tary passenger strand target sequences. The ratio of Renilla luciferase
(Rluc, reporter) to firefly luciferase (Fluc, internal control), normalized to
the negative control siRNA (siGFP) is shown. The experiments were
performed in triplicate. Error bar=1 S.D.
doi:10.1371/journal.pone.0028580.g004
Figure 5. The optimal mismatch structure could also be applied
to design shRNAs. shRNAs were constructed on murine pri-miR-150
backbone with no (mo) or m1+4+10 mismatches. The functionality was
tested as in Fig 1. Control indicates pri-miR-150 with scrambled mature
miR-150 sequence with the secondary structure kept intact. The
experiments were performed in triplicate. Error bar=1 S.D.
doi:10.1371/journal.pone.0028580.g005
MicroRNA Mimicking siRNA
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influences siRNA efficacy. It is noteworthy to point out that
m1+10 was significantly better than m1+4+10 in siR-109 and siR-
m659, suggesting that the exact optimal mismatch structure may
depend on the siRNA sequence context.
Discussion
Currently, the common practice to obtain a potent siRNA is to
design several siRNAs according to the siRNA design algorithm
and test their functionality. However in some cases, siRNAs have
to be designed to target particular sequences. For example, highly
conserved sequences shared by different virus species have to be
used for broad-spectrum antiviral activity. Such conserved regions
are few and are often not the ideal sequences predicted by the
currently available algorithms for siRNA design. Our method
provides an alternative method wherein generally any given
sequence, regardless of predictability by algorithms can be
optimized for gene silencing just by introducing mismatches in
the passenger strand. It has been reported previously that
introducing mismatch to the end of siRNA could enhance the
intended strand functionality [22,53,54,55]. In this study, we
systematically examined the effects of introducing both end and
internal mismatches and found that internal mismatches, in
combination with end mismatches can significantly increase the
functionality of siRNA. This method could also be applied to
shRNA design.
Why does introducing mismatches improve siRNA function?
Since siRNA has to be loaded into RISC to be functional,
mismatches may increase the loading efficiency and thereby
improve functionality. One of the major discoveries related to
RISC loading of siRNA is that end thermodynamic stability
dominates strand selectivity of RISC loading with the strand with
less stable 59 end showing the greatest propensity for loading
[22,53]. While this rule appears to be generally true, it is not rare
that siRNAs that defy this rule are also potent in gene silencing.
Moreover, siRNAs with perfect asymmetric thermodynamic ends
might also not function well [56,57]. Our study showed that in
addition to the end thermodynamic stability, changing the internal
thermodynamic stability by introducing mismatches at certain
internal positions can further increase siRNA functionality.
Kawamata et al reported that mismatches at the central position
enhance siRNA loading into pre-RISC while mismatches at the
seed region and mid region enhance siRNA unwinding [34,35,58].
It has also been reported that potent conventional siRNAs usually
have lower internal thermodynamic stability [7,59]. A recent
paper showed that lowering the thermodynamic stability in the
central position (position 9–12) by either introducing mismatches
or chemical modifications, could significantly improve the siRNA
potency [60]. Gu et al also showed that decreasing internal
thermodynamic stability of shRNA could enhance RISC matura-
tion by noncleaving Ago proteins, suggesting that unwinding of the
2 strands by Agos 1, 3 and 4 was enhanced by decreasing
thermodynamic stability [61]. Taken together, these studies
suggest that the overall thermodynamic pattern of siRNA is what
really determines the siRNA functionality, not only the end
thermodynamic stability. Introducing mismatches at certain
positions could optimize the overall thermodynamic pattern to
make the siRNA a better substrate for RISC loading and
maturation.
Several previous studies have tried to improve functionality and
strand-selecting accuracy of siRNAs. Chen et al reported that 59
phosphate is an important determinant for strand selection and 59-
O-methylation of siRNA passenger strand could effectively reduce
passenger strand functionality [38]. Several other chemical modifi-
cations have also been used to enhance functionality and decrease
the selecting of passenger strand [28,37,55,60,62,63,64,65].Other
methods used to improve functionality and strand-selecting accuracy
include incorporating 2 nt overhangs only in the guide strand,
making the passenger stand into two pieces or by shortening the
passenger strand by 3–4 nt [36,39,40]. However, none of these
methods can be applied to shRNA design. Our strategy provides yet
another way to enhance the functionality and strand selecting
accuracy of both si and shRNAs.
It is intriguing that introducing mismatches improved function-
ality in some siRNAs while not in other siRNAs. Our data
Figure 6. SiRNAs with and without mismatches are functional
in the context of individual Ago proteins. (a–c) The siRNAs with or
without mismatches were tested for functionality (as in Fig 1) in ES cells
expressing individual Ago proteins. The functional efficacy for siRNA
FVE
jw (a), siR-21 (b) and siR-HIV 59 UTR (c) is shown. The experiments
were performed in triplicate. Error bar=1 S.D.
doi:10.1371/journal.pone.0028580.g006
MicroRNA Mimicking siRNA
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although some of our data might provide clues to the question.
As shown in Fig. 2a, b, introducing a single mismatch at a
certain position in two different siRNA appears to have different
effects. For example, introducing a mismatch at position 4
showed no improvement in siR-21 compared to m0, but it had a
significant functionality improvement in siCS2. Moreover,
different mismatch combinationsh a v ev e r yd i f f e r e n te f f e c t so n
siR-21 and siCS2, suggesting that the effect of mismatches on
siRNA functionality might be siRNA sequence-dependent.
Different siRNA sequences need mismatches at different
positions to improve the thermodynamic feature. Our results
shown in Fig. 7a, also supports this hypothesis. It is also worth
mentioning that introducing mismatches did not further improve
the functionality in conventional siRNAs that already worked
well (such as FVE
jw as shown in Fig. 6a). The reason might be
that the thermodynamic pattern of these potent siRNAs might
already be optimal and can’t be further improved by introducing
mismatches. Thus, whether introducing mismatches to improve
functionality and in which position mismatches should be
introduced might depend on siRNA sequences. A larger scale
of study on the effect of mismatch-mediated thermodynamic
pattern changes in different siRNA sequences might shed light
on what is the optimal thermodynamic stability structure of
siRNA for RISC loading.
How the guide strand of siRNA or miRNA is loaded into
Argonaute proteins has been under intensive investigation. All 4
mammalian argonaute proteins are ubiquitously expressed and are
involved in miRNA-mediated gene repression (reviewed in
reference [47]). Recently, Wang et al reported that bacterially
expressed human Ago1 and Ago2, but not Ago3 and Ago4, possess
strand-dissociating activity of miRNA duplexes and passenger
strand cleavage activity of siRNA duplex [66]. However, Yoda et al
reported that although all 4 human Ago proteins showed
remarkably similar structural preferences for miRNA-like duplex-
es, only Ago2 could load and unwind siRNA duplexes efficiently to
generate mature RISC in vitro [35]. Our results, however suggest
that the different Ago proteins do not differentiate between si/
miRNA-based structure to generate mature RISC. The discrep-
ancy between these studies might be due to the different
experimental systems used. Since we performed experiments in
cell lines rather than Ago proteins purified in vitro, our conclusion
might reflect a more physiological context.
In summary, introducing mismatches in the passenger strand
generally improves the efficacy of siRNA by changing the end as
well as internal thermodynamic stability. Moreover this method
can also be applied to shRNA design to improve efficacy.
Materials and Methods
Cells, oligos, transfection and luciferase assay
293FT cells (Invitrogen) were cultured according to the
manufacturer’s instructions. The day before transfection, 293 FT
cells were trypsinized and diluted to 10
5 cells/ml and seeded in 96
well plates in a volume of 100 mL/ well. 2 pmol siRNA and 0.1 mg
psiCHECK2 plasmid harboring the target regions of testing
siRNA were co-transfected with lipofectamine 2000 (Invitrogen)
per the manufacturer’s instructions with modifications. First, the
siRNAs were mixed immediately with diluted lipofectamine 2000.
Second, plasmids and siRNAs complexes were made separately.
Third, the siRNAs were diluted at room temperature medium, not
37uC. Dual-Glo luciferase assays (Promega) were performed per
the manufacturer’s instructions one day after transfection.
To determine IC50, the siRNAs were serial diluted and tested
for functionality. In each dilution, control siRNA duplex was
added to ensure the presence of a constant amount of nucleic acid
in each transfection reaction.
For shRNA functionality test, 0.1 mg shRNA construct and
0.1 mg psiCHECK2 harboring the target sequence were co-
transfected into 10
4 293FT cells/well in a 96 well plate with
lipofectamine 2000 per the manufacturer’s instructions. Dual-Glo
luciferase assay was performed 24 hours later.
25 conventional stabilized siRNAs targeting highly conserved
region of various Flavivirus have been described [32]. All the other
RNA oligos were ordered from Sigma and sequences were listed in
Table S1.
Constructs
All the DNA oligos used for constructing psiCHECK2 target
reporters were listed in Table S2. DNA oligos were obtained from
IDT and Sigma. The oligos were annealed and inserted into
psiCHECK2 at XhoI and NotI site. Constructs were made for both
sense and antisense targets separately to test strand selection. New
constructs were made when mismatches were introduced into
passenger strands to make sure that the target sites were perfectly
complementary to the mismatched passenger strand. Full length c-
Figure 7. Both end and internal thermodynamic stability influence the siRNA efficacy. siRNAs targeting c-myb 39UTR (see Fig. 3c)
designed with indicated mismatches were tested for functionality as in Fig. 1.
doi:10.1371/journal.pone.0028580.g007
MicroRNA Mimicking siRNA
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lab.
Murine pri-miR-150 was used as the backbone for all the
shRNAs. 30 nt flanking sequence at both ends of pre-miR-150 was
included to ensure proper Drosha processing. The sequences of
shRNA were shown in Table S3. The shRNAs were inserted into
pLL3.7 vector at HpaI and XhoI site under the control of U6
promoter as described earlier [31].
Testing siRNA for antiviral activity
The assay was performed as previously described [31]. Briefly,
BHK21 cells were seeded in six well plates at 10
5 cells per well one
day before transfection. The siRNAs were transfected into cells
with lipofectamine 2000 per the manufacturer’s instructions.
8 hours after transfection, the cells were infected with West Nile
virus (WNV) (moi=1). 72 hours later, the cells were stained with
anti-West Nile Virus/Kunjin Envelope antibody (clone 3.67G,
Millipore), followed by flow cytometric analysis to determine
inhibition of virus replication.
Testing structural preference of Ago proteins
Ago1–4 expressing ES cells were cultured as described
previously [51]. 2 pmol siRNA and 0.1 mg psiCHECK vectors
harboring the target sequences were reverse transfected with
4610
4 cells per well in 96 well plates. Dual-Glo luciferase assay
were performed the next day.
Statistical analysis
Student’s t test (two-tailed, assuming equal variances on all
experimental data sets) was used to compare two groups of
independent samples.
Supporting Information
Figure S1 Mismatches increase functionality. Three
siRNAs that did not effectively inhibit West Nile virus replication
in our previous study (Figure 1a of reference (31)) were redesigned
by increasing the length to 22 nt and introducing mismatches in
the passenger strand corresponding to guide strand position 1 and
12 (m1+12) and tested for functionality as described in Fig. 1. C
represents conventionally designed 21 nt siRNA with no mis-
match.
(TIF)
Figure S2 siRNA targeting highly conserved regions in
the HIV 59UTR with and without mismatches were
tested for efficacy as in Fig. 1.
(TIF)
Table S1 The sequences of various mismatched siR-
NAs. ‘‘AS’’ represent the guide strand while ‘‘S’’ represent the
passenger strand.
(XLS)
Table S2 DNA oligos used to construct psiCHECH2
vector to determine siRNA repression efficiency. The
forward and reverse strands were annealed and cloned into
psiCHECK2.
(XLS)
Table S3 shRNA sequences. Mature duplex sequences are
marked in bold. Small cap represents the mismatched nucleotides.
(XLS)
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